Piper Sandler Downgrades Q32 Bio (NASDAQ:QTTB) to Neutral
Q32 Bio (NASDAQ:QTTB – Get Free Report) was downgraded by equities researchers at Piper Sandler from an “overweight” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat reports. They currently have a $4.00 price target on the stock, down from their prior price target of $20.00. Piper Sandler’s price target indicates […]
Q32 Bio (NASDAQ:QTTB – Get Free Report) was downgraded by equities researchers at Piper Sandler from an “overweight” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat reports. They currently have a $4.00 price target on the stock, down from their prior price target of $20.00. Piper Sandler’s price target indicates […]
